Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

British Medical Journal logoLink to British Medical Journal
. 1963 May 11;1(5340):1270–1275. doi: 10.1136/bmj.1.5340.1270

Treatment of Lead-poisoning with Oral Penicillamine

A Goldberg, Jacqueline A Smith, Ann C Lochhead
PMCID: PMC2123327  PMID: 13948657

Full text

PDF
1270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHENBRUCKER H., CARTWRIGHT G. E., GOLDBERG A., WINTROBE M. M. Studies on the biosynthesis of heme in vitro by avian erythrocytes. Blood. 1956 Sep;11(9):821–833. [PubMed] [Google Scholar]
  2. CHISOLM J. J., Jr, HARRISON H. E. Quantitative urinary coproporphyrin excretion and its relation to edathamil calcium disodium administration in children with acute lead intoxication. J Clin Invest. 1956 Oct;35(10):1131–1138. doi: 10.1172/JCI103367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DUDLEY H. R., RITCHIE A. C., SCHILLING A., BAKER W. H. Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia; report of two cases with autopsy findings. N Engl J Med. 1955 Mar 3;252(9):331–337. doi: 10.1056/NEJM195503032520901. [DOI] [PubMed] [Google Scholar]
  4. FOREMAN H., FINNEGAN C., LUSHBAUGH C. C. Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy. J Am Med Assoc. 1956 Mar 24;160(12):1042–1046. doi: 10.1001/jama.1956.02960470038010. [DOI] [PubMed] [Google Scholar]
  5. MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
  6. OHLSSON W. T. Penicillamine as lead-chelating substance in man. Br Med J. 1962 May 26;1(5290):1454–1456. doi: 10.1136/bmj.1.5290.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. PETERS H. A., WOODS S., EICHMAN P. L., REESE H. H. The treatment of acute porphyria with chelating agents: a report of 21 cases. Ann Intern Med. 1957 Nov;47(5):889–899. doi: 10.7326/0003-4819-47-5-889. [DOI] [PubMed] [Google Scholar]
  8. SEIGNETTE W. T., HAANEN C. A., JANSEN A. P., MAJOOR C. L. [The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning]. Folia Med Neerl. 1959 Jun;2:65–78. [PubMed] [Google Scholar]
  9. WALSHE J. M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487–495. doi: 10.1016/0002-9343(56)90066-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES